Archives eli-lilly

by in
Entry Author Date Location
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
West Coast Biotech Roundup: Hutch, Gilead, Soon-Shiong IPO & More 07/30/15 San Francisco
With New Alzheimer’s Data, Biogen Refines Plans For Big Trial 07/22/15 Boston
Analysis: NIH Guidelines Appear to Support UCSD in Alzheimer’s Study 07/13/15 San Diego
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More 05/22/15 San Diego
Companion Medical Raises $3M to Get Its Smart Insulin Pen to Market 05/21/15 San Diego
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Waksal’s Kadmon Spins Out Gene Therapy Group But Keeps Details Close 05/01/15 New York
With Fresh $14M, Tal Seeks Answers About Magnetic Depression Relief 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Arch, Flagship to Anchor NYCEDC’s $150M NY Biotech Fund 03/30/15 New York
Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline 03/20/15 Boston
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
Cancer Drug Developer G1 Therapeutics Closes $33M Series B Round 02/05/15 Raleigh Durham
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout 02/04/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
Qualcomm-Novartis Deal Portends Wave of Clinical Trial Innovation 01/15/15 San Diego
Migraine Drug Developer CoLucid Lands $37.1M for Phase 3 Trial 01/13/15 Raleigh Durham
Independent No More: Cubist Sold to Merck for $9.5B 12/08/14 Boston
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
Cubist CEO Bonney Steps Down After 12-Year Stint 10/20/14 Boston
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Alkermes Spinoff Civitas, Poised for IPO, Sells to Acorda for $525M 09/24/14 Boston
Page 1 of 11 next page »